drugset / Trial / NCT04403334

Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin

NCT04403334

Phase 4 Completed 114 enrolled Peregrine Eye and Laser Institute
RandomizedParallel-groupTriple-blindOther

Summary

Comparative safety study of intracameral levofloxacin versus moxifloxacin for postoperative infection prophylaxis

Timeline

Start
2018-01-02
Primary completion
2018-04-28
Completion
2018-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 0.1 ml Other
Subject Levofloxacin Small molecule 0.5 % Other
Subject Moxifloxacin Small molecule 0.1 ml Other
Subject Moxifloxacin Small molecule 0.5 % Other